# A Bioequivalence Study Of Ibuprofen 50mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.

> **NCT01350596** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 24 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Alivium®
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT01350596
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2011-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01350596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01350596, "A Bioequivalence Study Of Ibuprofen 50mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01350596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*